Yuki Miyamoto

25PUBLICATIONS
13CO-AUTHORS
Neurology and neuromuscular diseasesBiomaterialsCheminformatics and quantitative structure-activity relationshipsNeural engineeringHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 13, 2026
Signaling Through Girdin Underlies Excessive Cell Morphogenesis Resulting from Depletion of Neurodevelopmental Disorder-Related Neurexin-2.

|Jun 26, 2026
Hesperetin Rescues Amyloid Beta-Induced Defects in Neurite Outgrowth Under In Vitro Mild Cognitive Impairment-like Cellular Conditions.

|May 29, 2026
Structural basis for auto-inhibition of the Rac1/Cdc42 guanine nucleotide exchange factor DOCK6 by oligomer formation.

|May 04, 2026
The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells.

|Feb 27, 2026
Hesperetin, Acting Through Inhibition of c-Jun Signaling, Mitigates Hypomyelinating Disease-Associated Stop-Loss Claudin-11-Induced Defective Morphogenesis in Oligodendroglial FBD-102b Cells.

Yuki Miyamoto, Takeru Omata, Yuta Muraki

|Nov 13, 2025
Conformational alteration of DOCK5•ELMO1 signalosome on lipid membrane.

Takehiro Shinoda, Kazushige Katsura, Yoshiko Ishizuka-Katsura

Pageof 5

Frequent Collaborators

25 joint publications

Junji Yamauchi

8 joint publications

Katsuya Ohbuchi

6 joint publications

Hideji Yako

5 joint publications

Tomohiro Torii